Evidence map›Paper›PMID 39508866›Full record

ArticleCellular and molecular life sciences : CMLS2024

PARylation of GCN5 by PARP1 mediates its recruitment to DSBs and facilitates both HR and NHEJ Repair.

Debashmita Sarkar, Amartya Chakraborty, Shaina Mandi, Shilpee Dutt

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Debashmita SarkarShilpee Dutt Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, 410210, India.
Amartya ChakrabortyShilpee Dutt Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, 410210, India.
Shaina MandiShilpee Dutt Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, 410210, India.
Shilpee DuttShilpee Dutt Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, 410210, India. shilpeedutt@mail.jnu.ac.in.ORCID http://orcid.org/0000-0002-1292-9461

Funding

Department of Atomic Energy, Government of India 1/3(6)/2020/TMC/R&D-II/3805Department of Atomic Energy, Government of India 1/3(7)/2020/TMC/R&D-II/8823Department of Biotechnology, Ministry of Science and Technology, India BT/PR13863/MED/122/6/2016Indian Council of Medical Research BMS/TF/TRANS-NEURO/2014-3646/Dec-2015/48/MH/GOVTScience and Engineering Research Board EMR/2017/004994
6 · The paper itself

Abstract

Efficient DNA double strand break (DSB) repair is necessary for genomic stability and determines efficacy of DNA damaging cancer therapeutics. Spatiotemporal dynamics and post-translational modifications of repair proteins at DSBs dictate repair efficacy. Here, we identified a non-canonical function of GCN5 in regulating both HR and NHEJ repair post genotoxic stress. Mechanistically, genotoxic stress induced GCN5 recruitment to DSBs. GCN5 PARylation by PARP1 was essential for its recruitment, acetyltransferase activity and DSB repair function. Liquid chromatography-mass spectrometry (LC-MS) identified DNA-PKcs as part of GCN5 interactome. In-vitro acetyltransferase assays revealed that GCN5 acetylates DNA-PKcs at K3241 residue, a prerequisite for DNA-PKcs S2056 phosphorylation and DSB recruitment. Alongside, ChIP-qPCR revealed GCN5 mediates transcription of PRKDC via H3K27Ac acetylation in its promoter region (- 710 to - 554). Genetic perturbation of GCN5 also decreased CHEK1, NBN1, TP53BP1, POL-L transcription and abrogated ATM, BRCA1 activation. Accordingly, GCN5 loss led to persistent ɣ-H2AX foci formation, compromised in-vivo HR-NHEJ and caused GBM radio-sensitization. Importantly, PARP1 inhibition phenocopied GCN5 loss. Together, this study identifies an untraversed DSB repair function of GCN5 and provides mechanistic insights into transcriptional as well as post-translational regulation of pivotal HR-NHEJ factors. Alongside, it highlights the translational importance of PARP1-GCN5 axis in mediating GBM radio-resistance.

Indexed as

DNA Breaks, Double-StrandedDNA End-Joining Repairp300-CBP Transcription FactorsPoly (ADP-Ribose) Polymerase-1AcetylationAnimalsCell Line, TumorDNA-Activated Protein KinaseHumansMiceNuclear Proteinsp300-CBP-Associated FactorPhosphorylationPoly ADP RibosylationProtein Processing, Post-TranslationalRecombinational DNA RepairDNA-Activated Protein KinaseNuclear Proteinsp300-CBP-Associated Factorp300-CBP Transcription FactorsPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1PRKDC protein, humanAcetylationBrain tumorDNA damage responseDNA-PKcsDSB RepairEpigeneticsGCN5GlioblastomaPARP1PARylationRadio-sensitization

Identifiers

PMID39508866
PMCPMC11544116

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.